phosphatidylcholines has been researched along with glimepiride in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (glimepiride) | Trials (glimepiride) | Recent Studies (post-2010) (glimepiride) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 956 | 340 | 474 |
Protein | Taxonomy | phosphatidylcholines (IC50) | glimepiride (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.39 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.85 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 6.86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, B; Guo, XL; Li, JJ; Zhang, P; Zheng, ZS | 1 |
1 other study(ies) available for phosphatidylcholines and glimepiride
Article | Year |
---|---|
The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data.
Topics: Adamantane; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Dipeptides; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Sulfonylurea Compounds; Treatment Outcome | 2019 |